DigestRedComo funciona
Red
/
Empresas
SO
No verificado

SOTIO Biotech

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaOncologíaSalud

12 Comunicados de prensa

Ver todos los comunicados de prensa
12/11/2025
OncologĂ­a
Salud
Medicina - Varios
Ciencia
Farmacéutica
BiotecnologĂ­a
Finanzas
Industria
Eventos
SOTIO Presents Positive Results from Non-Human Primate Study of SOT106, a Potential Best-in-Class ADC for Treatment of Sarcoma
Fuente
SOTIO Biotech
Editor
Business Wire
1.00
0
03/11/2025
BiotecnologĂ­a
Farmacéutica
Salud
OncologĂ­a
Mercado laboral
SOTIO Announces Promotion of Vivi Boura to Chief Medical Officer
Fuente
SOTIO Biotech
Editor
Business Wire
1.00
0
30/10/2025
Eventos
Industria
OncologĂ­a
Salud
Ciencia
Farmacéutica
BiotecnologĂ­a
SOTIO to Present Data Highlighting Progress Across ADC and Immunocytokine Programs at Upcoming Scientific Conferences
Fuente
SOTIO Biotech
Editor
Business Wire
1.00
0
02/10/2025
OncologĂ­a
Salud
Medicina - Varios
Ciencia
Farmacéutica
BiotecnologĂ­a
Mercado laboral
SOTIO Strengthens Leadership Team with Appointments of Amy Jensen-Smith as Chief Scientific Officer and Ulrich Moebius as Chief Development Officer
Fuente
SOTIO Biotech
Editor
Business Wire
1.00
0
29/04/2025
Eventos
Industria
OncologĂ­a
Salud
Medicina - Varios
Ciencia
Farmacéutica
BiotecnologĂ­a
SOTIO Reports Promising Preclinical Data on Antibody-Drug Conjugates SOT109 and SOT106, Underscoring Best-in-Class Potential for Solid Tumor Treatments
Fuente
SOTIO Biotech
Editor
Business Wire
1.00
0
26/03/2025
Eventos
Industria
OncologĂ­a
Salud
Medicina - Varios
Ciencia
Farmacéutica
BiotecnologĂ­a
SOTIO to Present Preclinical Data on Lead Antibody-Drug Conjugates, SOT106 and SOT109, at 2025 AACR Annual Meeting
Fuente
SOTIO Biotech
Editor
Business Wire
1.00
0
13/03/2025
Mercado laboral
Industria
Ciencia
BiotecnologĂ­a
Farmacéutica
OncologĂ­a
Sanidad
Salud
SOTIO Expands ADC Pipeline and Synaffix Collaboration to Develop Two Novel Bispecific Candidates, SOT112 and SOT113
Fuente
SOTIO Biotech
Editor
Business Wire
1.00
0
03/03/2025
BiotecnologĂ­a
Sanidad
Salud
Farmacéutica
OncologĂ­a
Ciencia
Medicina - Varios
Eventos
Industria
SOTIO Unveils Promising Preclinical Data on SOT109, a Next-Gen ADC Targeting Cadherin-17 (CDH17) for Colorectal Cancer
Fuente
SOTIO Biotech
Editor
Business Wire
1.00
0
09/01/2025
Mercado laboral
Ciencia
BiotecnologĂ­a
Farmacéutica
OncologĂ­a
Salud
Medicina - Varios
SOTIO Advances Colorectal Cancer ADC Program, SOT109, and Licenses Fully Human Antibodies from Biocytogen for Novel Tumor Target
Fuente
SOTIO Biotech
Editor
Business Wire
1.00
0
07/11/2024
Eventos
Industria
BiotecnologĂ­a
Salud
Farmacéutica
Medicina - Varios
OncologĂ­a
SOTIO Showcases New Data on SOT201 Immunocytokine, VICTORIA-01 Clinical Study, and BOXR CAR-T Advancements at 2024 SITC Annual Meeting
Fuente
SOTIO Biotech
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0